RE: Bloomberg Interview : Variants won’t be an obstacle1 Apr 2021 01:37
LTH Here.
Imagine the share price now if they had switched their attention from Sau Paulo to Manaus when P1 was first in the headlines. Also if conclusive, fast tracked and saved many lives.
As a resident here in Brazil, we have in Southern Bahia, Cinovax, Astra, Phizer, Sputnik5 and another....big problem is going to be the second jab as they keep running out. People will be given a jab with a different vaccination...how does that sound. Pretty frightening.